JPH04122249A - Ovulation period judging tool - Google Patents
Ovulation period judging toolInfo
- Publication number
- JPH04122249A JPH04122249A JP24130290A JP24130290A JPH04122249A JP H04122249 A JPH04122249 A JP H04122249A JP 24130290 A JP24130290 A JP 24130290A JP 24130290 A JP24130290 A JP 24130290A JP H04122249 A JPH04122249 A JP H04122249A
- Authority
- JP
- Japan
- Prior art keywords
- vagina
- judging
- period
- increase
- ovulation period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000016087 ovulation Effects 0.000 title claims abstract description 36
- 238000006243 chemical reaction Methods 0.000 claims abstract description 23
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims abstract description 17
- 210000001215 vagina Anatomy 0.000 claims abstract description 17
- 238000012360 testing method Methods 0.000 claims abstract description 8
- 210000003756 cervix mucus Anatomy 0.000 claims description 21
- 210000002919 epithelial cell Anatomy 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 230000001568 sexual effect Effects 0.000 claims description 6
- 230000003780 keratinization Effects 0.000 claims description 5
- 230000000624 ovulatory effect Effects 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
- 238000004299 exfoliation Methods 0.000 abstract description 8
- 238000004040 coloring Methods 0.000 abstract description 2
- 238000003780 insertion Methods 0.000 abstract description 2
- 230000037431 insertion Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract 6
- 230000006003 cornification Effects 0.000 abstract 3
- 210000003097 mucus Anatomy 0.000 abstract 3
- 210000000981 epithelium Anatomy 0.000 abstract 2
- 230000036760 body temperature Effects 0.000 description 12
- 230000007423 decrease Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 230000004720 fertilization Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000010902 straw Substances 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000027758 ovulation cycle Effects 0.000 description 4
- 230000035558 fertility Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
- 102000006771 Gonadotropins Human genes 0.000 description 2
- 108010086677 Gonadotropins Proteins 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229940028334 follicle stimulating hormone Drugs 0.000 description 2
- 239000002622 gonadotropin Substances 0.000 description 2
- 229940094892 gonadotropins Drugs 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- YWYQTGBBEZQBGO-BERLURQNSA-N Pregnanediol Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](O)C)[C@@]2(C)CC1 YWYQTGBBEZQBGO-BERLURQNSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- YWYQTGBBEZQBGO-UHFFFAOYSA-N UC1011 Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(O)C)C1(C)CC2 YWYQTGBBEZQBGO-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
本発明は、女性性周期における排卵期に一致して、膣内
に現われるところの、非排卵期には通常では見られない
変化である子宮頚管粘液の分泌量増加や粘性の低下、膣
内上皮細胞の角化剥脱量の増加、膣分泌物の水素イオン
濃度の上昇等の変化を利用し、女性が自己の排卵期の客
観的な確認を可能にすることによって、排卵期は受胎期
間に相当することから、これが受胎調節にも役立てられ
る排卵期判定用具に関するものである6The present invention addresses changes in the secretion of cervical mucus and decrease in its viscosity that occur in the vagina during the ovulatory period of the female sexual cycle, but which are not normally seen during the non-ovulatory period. By making it possible for women to objectively confirm their own ovulation period by utilizing changes such as an increase in the amount of keratinization of epithelial cells and an increase in the hydrogen ion concentration of vaginal secretions, the ovulation period can be compared to the fertilization period. Since this is equivalent, this is related to an ovulation stage determination tool that is also useful for fertility control6.
従来、女性が自分の性周期における排卵期を自分で知る
方法としては、帯下感や腹痛等の自覚症状の他、主に受
胎調節を目的として毎日の覚醒起床時に体温を測定する
方法(萩野式禁欲法と呼ばれるもの)があった。この後
者の方法は、長期の計測習慣により得られる体温の、高
温相と低温相の周期的変化を基礎体温変化として用い、
排卵日は予定月経開始の第12〜16日の5日間で、受
胎調節にはこれに受精能力期間の3日間を加え、12〜
19日の8日間を受胎期間とするものである。
この他、何らかの理由で医師が排卵期を確認する要があ
る場合は、医師によって主に、性ホルモンの一つである
被検者の尿中プレグナンジオール測定(排卵後24〜4
8時間後より増加する)、子宮体内膜のバイオプシーに
よる細胞の検索、j宮頸管粘液の量や粘性の測定、他に
は膣内容のト索等が行われることが多いが、これらは測
定をするための分析器や器具の設備が必要であり、医撹
機関外での検査は不可能である。Conventionally, the methods for women to know the ovulation period in their sexual cycle include subjective symptoms such as leucorrhoea and abdominal pain, as well as a method of measuring body temperature every day when waking up, mainly for the purpose of fertility control (Hagino et al. There was something called the ceremonial abstinence law. This latter method uses periodic changes in body temperature between high and low temperatures, obtained through long-term measurement habits, as changes in basal body temperature.
The day of ovulation is the 5-day period from the 12th to the 16th day of the expected menstrual period, and for fertility control, add the 3 days of the fertile period to this,
The 8-day period on the 19th is the conception period. In addition, if the doctor needs to confirm the ovulation period for some reason, the doctor will mainly measure the subject's urinary pregnanediol, which is one of the sex hormones (24 to 4 days after ovulation).
(increases after 8 hours), searching for cells by biopsy of the uterine lining, measuring the amount and viscosity of cervical mucus, and probing the contents of the vagina. Analyzers and equipment are required to carry out this test, and testing outside of medical institutions is not possible.
従来の排卵期を知る方法のうち、基礎体温をj定する方
法は、毎朝の体温測定を習慣作業とし、その測定結果を
作表する必要があり、面倒なことから本体を継続できる
女性は多くない。また、月経周期は規01ノ正しい女性
でも変動があり、更に病気による発熱のばか各種の生活
条件により測斤自体が不正確になったり、人によっては
体温変化が明らかでない例もあり、この方法は誰でもが
一様に利用できるものではない。
尚、従来は女性が受胎したか否かを判定する妊娠診断検
査法として、体外診断用検査薬により1胎した女性の尿
中の出現量が増える糖蛋白質ホルモン、例えばゴナドト
ロピンを検出することによって妊娠反応を陽性、陰性と
いう形式で判定できる妊娠判定用品があるが、それは事
前に受胎期間である排卵期を知るものではなく、あくま
でも妊娠が成立したか否かを判定するものであった。Among the conventional methods of determining the ovulation period, the method of determining basal body temperature requires measuring body temperature every morning as a habit and tabulating the measurement results, which is a hassle that many women do not continue using. do not have. In addition, even women with regular menstrual cycles experience fluctuations, and the measurement itself may become inaccurate due to fever due to illness, various living conditions, and changes in body temperature may not be obvious for some people. is not available equally to everyone. Conventionally, pregnancy diagnostic tests have been used to determine whether a woman has conceived or not, by using in vitro diagnostic tests to detect glycoprotein hormones, such as gonadotropins, which appear in increasing amounts in the urine of women with one gestation. There are pregnancy test products that can determine whether a reaction is positive or negative, but they do not know in advance the ovulation period, which is the fertilization period, but are only used to determine whether or not a pregnancy has occurred.
本発明の目的は、女性が特別な前準備や習慣的作業を・
必要とせずに、自己の排卵期、つまり受胎期間であるか
否かを、容易な自己操作のみで、しかも操作したその場
で直ちに判定できる排卵期判定用具を提供することにあ
る。The purpose of the invention is to help women perform special preparations and routine tasks.
To provide an ovulation period determination tool which can immediately determine whether or not it is one's own ovulation period, that is, the fertilization period, by simple self-operation and on the spot of operation without the need for such a tool.
本件発明者は本件発明の開発に先立って、個々の女性が
夫々に異なった体質や生活条件によって変動する性周期
の中で、自覚症状や日数計算、或は基礎体温測定法のみ
に頼らずに、しかも個々の都合にあった使用ができる排
卵期判定用具を実現すべきこと、そのためには、その用
具の使用方法をどうするかについて鋭意研究した結果、
第3図に示す女性の性周期において変化する各種ホルモ
ン、基礎体温の他に、膣内で排卵期に一致して確認でき
る子宮頸管粘液量の増加と粘性の低下、B内上皮細胞剥
脱量の増加、膣分泌物の水素イオン濃度の上昇変化を直
接捉えることを見出した。
第3図に表されるa、b、c、dは夫々抗体化ホルモン
(LH)、卵胞刺激ホルモン(FSH)、エストロゲン
、プロゲステロンの分泌量の増減を示す線図、eは基礎
体温の変化を示す線区、fは子宮頸管粘液量、膣内上皮
細胞剥脱量、膣分泌物水素イオン濃度の変化を示す線図
である。同図の縦軸は線図a、b、c、dの場合は分泌
量を、線図eの場合は基礎体温の高低値を、線図fの場
合は子宮頸管粘液量と上皮細胞剥脱量の増加、膣分泌物
水素イオン濃度の上昇を表わし、横軸は日時経過を表す
。
この図から理解し得ることは各種の性腺刺激ホルモン、
基礎体温、子宮頸管粘装置、膣上皮細胞剥脱量、膣分泌
物水素イオン濃度等の増減変化と性周期とは相関関係が
あり、特にそれは排卵期に致しで著しい変動を示すとい
うことである。
ちなみに排卵期の膣内変化は、エストロゲンの作用によ
って子宮頸管粘液量が増加し、その性状は水様イヒし粘
性は低下。膣内上皮細胞の角化剥脱が盛んで白血球は著
減し、膣分泌物の水素イオン濃度が上昇、細菌も減少す
る。
本発明の排卵期判定用具はこのような知見に基づいて開
発されたものであり、子宮頸管粘液量の増加と粘性の低
下、膣内上皮細胞角化剥脱、水素イオン濃度の上昇の複
数現象の同期変化を利用して排卵期を判定するものであ
る。
同排卵期判定用具は第1図のように女性の膣内に挿入で
きる判定用具本体1に、排卵期に一致した前記膣内変化
に対して発色或は変色する判定用反応薬2が取付けられ
でいるものである。Prior to the development of the present invention, the present inventor discovered that each woman's sexual cycle fluctuates depending on her different constitution and living conditions, without relying solely on subjective symptoms, counting the number of days, or measuring basal body temperature. As a result of intensive research into how to use the tool, we realized that we should create an ovulation period determination tool that can be used according to individual convenience.
In addition to the various hormones and basal body temperature that change during a woman's sexual cycle as shown in Figure 3, there is an increase in the amount of cervical mucus and a decrease in viscosity that can be observed in the vagina during the ovulation period, and an increase in the amount of exfoliation of epithelial cells in the B. We found that this method can directly capture changes in the hydrogen ion concentration of vaginal secretions. In Figure 3, a, b, c, and d are diagrams showing increases and decreases in the secretion of antibody-forming hormone (LH), follicle-stimulating hormone (FSH), estrogen, and progesterone, respectively, and e is a diagram showing changes in basal body temperature. The line section f is a diagram showing changes in the amount of cervical mucus, the amount of exfoliation of vaginal epithelial cells, and the hydrogen ion concentration of vaginal secretions. The vertical axis of the figure is the secretion amount in the case of lines a, b, c, and d, the high and low values of basal body temperature in the case of line e, and the amount of cervical mucus and epithelial cell exfoliation in the case of line f. , and the increase in vaginal secretion hydrogen ion concentration, and the horizontal axis represents the passage of time and date. What can be understood from this diagram is that various gonadotropins,
There is a correlation between changes in basal body temperature, cervical mucus, the amount of vaginal epithelial cell exfoliation, hydrogen ion concentration in vaginal secretions, etc. and the estrous cycle, and there is a particular correlation with the estrous cycle, which shows marked fluctuations especially during the ovulation period. By the way, changes in the vagina during ovulation include an increase in the amount of cervical mucus due to the action of estrogen, which becomes watery and less viscous. The keratinization of vaginal epithelial cells is active, the number of white blood cells decreases significantly, the hydrogen ion concentration of vaginal secretions increases, and the number of bacteria decreases. The ovulation stage determination tool of the present invention was developed based on this knowledge, and is capable of addressing multiple phenomena: an increase in cervical mucus volume and a decrease in viscosity, exfoliation of vaginal epithelial cells, and an increase in hydrogen ion concentration. This method uses synchronous changes to determine the ovulation period. As shown in Fig. 1, the ovulation stage determination tool has a determination tool body 1 that can be inserted into a woman's vagina, and a determination reaction drug 2 that develops or changes color in response to changes in the vagina that correspond to the ovulation stage is attached. It is something that exists.
【作用】
本発明の排卵期判定用具は第1図のように判定用具本体
1に子宮頚管粘液粘性の低下に比例する反応促進薬、角
化細胞染色藁、水素イオン温度指示薬等の判定用反応薬
2が一端に取付けられているので、判定用具本体lの所
持側を手指で保持し、その反対側の反応部を先端から被
検者の膣内に挿入することによって、同膣内における子
宮頚管粘液粘性の低下と上皮細胞角化剥脱量の増加、水
素イオン濃度の上昇に基づいて同判定用反応藁2が発色
或は変色する。
子宮頸管粘液量の増加と粘性の低下、膣内上皮細胞角化
剥脱量の増加、水素イオン濃度の上昇は第3図に示すよ
うに排卵期に一致して著変するので、前記判定用反応薬
2の発色或は変色の程度に基づいて排卵期か否かを自分
で挿入操作をしたその場で判定することができる。[Function] As shown in FIG. 1, the ovulation stage determination tool of the present invention includes a determination tool body 1 containing a reaction promoter proportional to the decrease in cervical mucus viscosity, keratinocyte staining straw, a hydrogen ion temperature indicator, etc. Since the reactive drug 2 is attached to one end, hold the holding side of the evaluation tool body l with your fingers and insert the reactive part on the opposite side into the subject's vagina from the tip. The reaction straw 2 for determination develops or changes color based on a decrease in cervical mucus viscosity, an increase in the amount of epithelial cell keratinization, and an increase in hydrogen ion concentration. As shown in Figure 3, the increase in the amount of cervical mucus and the decrease in viscosity, the increase in the amount of keratinization of vaginal epithelial cells, and the increase in hydrogen ion concentration change significantly in accordance with the ovulation period, so the above-mentioned reaction for determination Based on the degree of color development or discoloration of the drug 2, it is possible to determine whether or not it is the ovulation period on the spot after the insertion operation.
本発明の排卵期判定用具の一実施例を示す第】図におい
て1は判定用具本体である。この判定具本体lとしては
例えば綿棒に似た形の細長て1女性の膣内に挿入し易く
、膣内部に損傷を与えに(い形状のものが使用される。
第1図の判定用具本体lは長平方向全長にわたって均一
径の丸棒状にしであるが、判定用具本体1の形状やW4
造は図示したもの以外であってもよい。例えば第2図の
ように長平方向一端を径の大きい球状に形成してもよい
。このようにすると表面積が大となるので反応参加面も
広くなり、結果の確実性が向上する。
また判定用具本体lの材料としては紙質、プラスチック
、多孔質ゴム等の柔らかくて、変質がなく、安価で、使
い捨てに適するものがよい。
同判定用具本体1の長子方向一端には判定用反応薬付着
部3が設けられている。この判定用反応薬付着部3には
例えば脱脂綿質が取付けられており、この脱脂綿質に子
宮頚管粘液粘性に比例した反応促進薬、剥脱した角化上
皮細胞の染色薬、水素イオン濃度指示薬等の判定用反応
薬2が含浸されている。
尚、前記判定用具本体lに吸水性のよい材料を使用した
場合は、判定用反応薬付着部3に脱脂綿質を取付けずに
、判定用具本体1に直接判定用反応薬2を塗布或は含浸
させておいてもよい。
判定用反応薬2としては例えば角化剥脱細胞の発色には
へマドキシリンエオシン染色藁、メチレン青染色薬、水
素イオン濃度の指示薬にはリドマス試験藁等がある。
【発明の効果]
本発明の排卵期判定用具は次のような効果がある。
a、受胎期間である排卵期に一致して変動する膣内現象
を直接判定するので、受胎期間であるか否かが理論や計
算等の間接的な方法でなく、被検者個々の性周期や生活
条件に従って確実に確認できる。
b 受胎期間である排卵期に特徴的な、膣内の現象を直
接発色或は変色させる判定用反応薬2が判定用具本体l
に取付けられているので、受胎期間か否かの判定は同判
定用反応藁2の色を見るだけで良く、通常は誤判定の要
素を除外できる。
C−医師等の専門家でなく素人が一人で使用でき、しか
も反射操作したその場で排卵期か否かの判定ができるの
で非常に便利である。
d1本発明の排卵期判定用具を使用することによって、
被検者が自己の排卵期を確認するために必要だった前準
備や習慣的作業から解放される。In the figure showing an embodiment of the ovulation period determining tool of the present invention, 1 is the main body of the determining tool. The main body of this test tool is, for example, a long and thin one resembling a cotton swab that is easy to insert into a woman's vagina and has a shape that does not cause damage to the inside of the vagina. l is a round bar with a uniform diameter over the entire length in the longitudinal direction, but depending on the shape of the judgment tool main body 1 and W4
Structures other than those shown may be used. For example, as shown in FIG. 2, one end in the elongated direction may be formed into a spherical shape with a large diameter. In this way, the surface area becomes large, so the surface for participating in the reaction becomes large, and the reliability of the results is improved. The material for the main body 1 of the determination tool is preferably one that is soft, does not deteriorate, is inexpensive, and is suitable for disposable use, such as paper, plastic, or porous rubber. A determination reaction agent attachment portion 3 is provided at one end in the longitudinal direction of the determination tool main body 1. For example, absorbent cotton is attached to this judgment reaction agent attachment part 3, and this absorbent cotton includes a reaction promoter proportional to the viscosity of cervical mucus, a dye for exfoliated keratinized epithelial cells, a hydrogen ion concentration indicator, etc. It is impregnated with a reaction agent 2 for determination. In addition, when a material with good water absorption is used for the determination tool main body 1, the reaction agent 2 for determination is directly applied or impregnated onto the determination tool main body 1 without attaching absorbent cotton to the reaction agent attachment part 3 for determination. You can leave it alone. As the reaction agent 2 for determination, for example, hemadoxylin and eosin staining straw and methylene blue staining agent are used for coloring exfoliated cells, and Lidomus test straw is used as an indicator for hydrogen ion concentration. [Effects of the Invention] The ovulation period determination tool of the present invention has the following effects. a. Since the vaginal phenomena that fluctuate in accordance with the ovulation period, which is the fertilization period, are directly determined, it is not determined whether the fertilization period is reached by indirect methods such as theory or calculation, but by the estrous cycle of the individual test subject. It can be confirmed reliably according to the living conditions and living conditions. b The reaction drug 2 for determination that directly develops or changes the color of the phenomenon in the vagina characteristic of the ovulation period, which is the period of conception, is the main body of the determination tool l
Therefore, it is sufficient to judge whether or not the fertilization period is reached by simply looking at the color of the reaction straw 2 for this judgment, and normally the factors of misjudgment can be excluded. C-It is very convenient because it can be used by an amateur alone, not by a specialist such as a doctor, and it is possible to determine whether or not it is the ovulation period on the spot by reflex operation. d1 By using the ovulation period determination tool of the present invention,
The test subject is freed from the preparations and routine work required to confirm his or her own ovulation period.
第1図、第2図は本発明の排卵期判定用具の異なる例を
示す説明図、第3図は女性の性周期における各種ホルモ
ン、基礎体温、子宮頸管粘液量。
粘性の変化、表層角化細胞剥脱量、水素イオン濃度等の
変動を示す説明図である。
1は判定用具本体
2は判定用反応薬FIGS. 1 and 2 are explanatory diagrams showing different examples of the ovulation period determination tool of the present invention, and FIG. 3 shows various hormones, basal body temperature, and cervical mucus levels during a woman's sexual cycle. FIG. 2 is an explanatory diagram showing changes in viscosity, amount of surface keratinocyte exfoliation, hydrogen ion concentration, etc. 1 is the determination tool body 2 is the reaction drug for determination
Claims (1)
における排卵期に一致して膣内に現われるところの、非
排卵期には通常では見られない卵巣、子宮の機能を含め
た変化である子宮頚管粘液の分泌量増加や粘性の低下、
膣内上皮細胞の角化剥脱量の増加、膣分泌物の水素イオ
ン濃度の上昇等に対して発色或は変色する判定用反応薬
2が取付けられていることを特徴とする排卵期判定用具
。The test tool body 1, which can be inserted into a woman's vagina, detects changes in the function of the ovaries and uterus that appear in the vagina during the ovulatory period of the female sexual cycle, but are not normally seen during the non-ovulatory period. Increased secretion and decreased viscosity of certain cervical mucus,
An ovulation period determination tool, characterized in that a reaction agent 2 for determination is attached that develops or changes color in response to an increase in the amount of keratinization of vaginal epithelial cells, an increase in the hydrogen ion concentration of vaginal secretions, etc.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24130290A JPH04122249A (en) | 1990-09-13 | 1990-09-13 | Ovulation period judging tool |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24130290A JPH04122249A (en) | 1990-09-13 | 1990-09-13 | Ovulation period judging tool |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH04122249A true JPH04122249A (en) | 1992-04-22 |
Family
ID=17072262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24130290A Pending JPH04122249A (en) | 1990-09-13 | 1990-09-13 | Ovulation period judging tool |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH04122249A (en) |
-
1990
- 1990-09-13 JP JP24130290A patent/JPH04122249A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5916173A (en) | Methods and apparatus for monitoring fertility status in the mammalian vagina | |
| Luciano et al. | Temporal relationship and reliability of the clinical, hormonal, and ultrasonographic indices of ovulation in infertile women | |
| US4534362A (en) | Method and apparatus for detection of fertility | |
| US5837197A (en) | Positive fertility testing and reproductive health system | |
| US4036212A (en) | Method of predetermining time of ovulation in women and in animals to control conception | |
| Viergiver et al. | Measurement of the cyclic variations in the quantity of cervical mucus and its correlation with basal temperature | |
| US4246907A (en) | Method for identifying an ovulation phase within a menstrual cycle of a woman | |
| Eggert-Kruse et al. | Clinical significance of crossed in vitro sperm-cervical mucus penetration test in infertility investigation | |
| EP0871402B1 (en) | Method and apparatus for determining the fertility status of women | |
| US3436186A (en) | Test method for assessing ovulatory function | |
| Baker et al. | A possible method for the detection of ovulation and the determination of the duration of the fertile period | |
| US5914271A (en) | Fertility test | |
| HUT74629A (en) | Methods, devices and test kits for monitoring ovulation | |
| JPH04122249A (en) | Ovulation period judging tool | |
| Moghissi | Ovulation detection | |
| Allen | The time of ovulation in the menstrual cycle of the monkey, Macacus rhesus. | |
| HARVEY et al. | Certain characteristics of cervical mucus in relation to the menstrual cycle | |
| Doyle et al. | The new fertility testing tape: a predictive test of the fertile period | |
| Raeside et al. | Arborization of cervical mucus in the ewe | |
| CN203551567U (en) | HCG (human chorionic gonadotropin) concentration comparison device | |
| CN2266992Y (en) | Testing-kit for ovulation-period determination | |
| RU200738U1 (en) | Device for determining the pH of the vagina in sows | |
| Sprague | Diagnosis of early pregnancy by cervical mucus smears | |
| Seki et al. | Correlation between urinary oestrogen levels determined by haemagglutination inhibition reaction and serum oestradiol levels determined by radioimmunoassay | |
| Moghissi et al. | Documentation of ovulation |